SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-044731
Filing Date
2024-05-17
Accepted
2024-05-17 16:01:51
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205718-10q_abvcbio.htm   iXBRL 10-Q 1134499
2 CERTIFICATION ea020571801ex31-1_abvcbio.htm EX-31.1 10409
3 CERTIFICATION ea020571801ex31-2_abvcbio.htm EX-31.2 10389
4 CERTIFICATION ea020571801ex32-1_abvcbio.htm EX-32.1 4611
5 CERTIFICATION ea020571801ex32-2_abvcbio.htm EX-32.2 4697
  Complete submission text file 0001213900-24-044731.txt   7086711

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20240331.xsd EX-101.SCH 72614
7 XBRL CALCULATION FILE abvc-20240331_cal.xml EX-101.CAL 43848
8 XBRL DEFINITION FILE abvc-20240331_def.xml EX-101.DEF 349510
9 XBRL LABEL FILE abvc-20240331_lab.xml EX-101.LAB 612044
10 XBRL PRESENTATION FILE abvc-20240331_pre.xml EX-101.PRE 353150
91 EXTRACTED XBRL INSTANCE DOCUMENT ea0205718-10q_abvcbio_htm.xml XML 763751
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 24959444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)